Boston Common Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,594
| Closed | -$614K | – | 312 |
|
|
2022
Q4 | $614K | Sell |
6,594
-887
| -12% | -$85.6K | 0.03% | 184 |
|
|
2022
Q3 | $713K | Buy |
7,481
+78
| +1% | +$7.72K | 0.04% | 183 |
|
|
2022
Q2 | $686K | Buy |
7,403
+396
| +6% | +$38.6K | 0.03% | 187 |
|
|
2022
Q1 | $709K | Sell |
7,007
-519
| -7% | -$54.5K | 0.03% | 190 |
|
|
2021
Q4 | $776K | Buy |
7,526
+1,173
| +18% | +$108K | 0.03% | 184 |
|
|
2021
Q3 | $539K | Buy |
6,353
+38
| +0.6% | +$3.18K | 0.02% | 205 |
|
|
2021
Q2 | $527K | Buy |
6,315
+310
| +5% | +$25.4K | 0.02% | 214 |
|
|
2021
Q1 | $452K | Buy |
6,005
+44
| +0.7% | +$3.21K | 0.03% | 215 |
|
|
2020
Q4 | $407K | Buy |
+5,961
| New | +$388K | 0.03% | 210 |
|
|
2019
Q4 | – | Sell |
-3,240
| Closed | -$204K | – | 214 |
|
|
2019
Q3 | $204K | Buy |
+3,240
| New | +$192K | 0.03% | 184 |
|
|
2019
Q2 | – | Sell |
-8,677
| Closed | -$468K | – | 186 |
|
|
2019
Q1 | $468K | Sell |
8,677
-309
| -3% | -$19.1K | 0.06% | 166 |
|
|
2018
Q4 | $589K | Buy |
8,986
+3,981
| +80% | +$297K | 0.09% | 142 |
|
|
2018
Q3 | $394K | Hold |
5,005
| – | – | 0.05% | 171 |
|
|
2018
Q2 | $322K | Hold |
5,005
| – | – | 0.04% | 175 |
|
|
2018
Q1 | $311K | Sell |
5,005
-10,290
| -67% | -$738K | 0.04% | 178 |
|
|
2017
Q4 | $1.11M | Sell |
15,295
-38,360
| -71% | -$2.79M | 0.13% | 125 |
|
|
2017
Q3 | $4.36M | Sell |
53,655
-1,635
| -3% | -$129K | 0.54% | 74 |
|
|
2017
Q2 | $4.45M | Sell |
55,290
-14,888
| -21% | -$1.18M | 0.59% | 66 |
|
|
2017
Q1 | $5.51M | Buy |
70,178
+1,041
| +2% | +$83.1K | 0.75% | 47 |
|
|
2016
Q4 | $5.46M | Sell |
69,137
-4,639
| -6% | -$375K | 0.8% | 44 |
|
|
2016
Q3 | $6.57M | Buy |
73,776
+3,610
| +5% | +$341K | 0.36% | 96 |
|
|
2016
Q2 | $6.72M | Buy |
70,166
+6,726
| +11% | +$670K | 0.39% | 89 |
|
|
2016
Q1 | $6.58M | Sell |
63,440
-4,200
| -6% | -$408K | 0.37% | 92 |
|
|
2015
Q4 | $6.61M | Buy |
67,640
+16,300
| +32% | +$1.6M | 0.37% | 93 |
|
|
2015
Q3 | $4.95M | Buy |
51,340
+45,910
| +845% | +$4.83M | 0.3% | 107 |
|
|
2015
Q2 | $569K | Sell |
5,430
-115
| -2% | -$11.8K | 0.03% | 227 |
|
|
2015
Q1 | $572K | Buy |
5,545
+1,285
| +30% | +$130K | 0.03% | 230 |
|
|
2014
Q4 | $410K | Buy |
+4,260
| New | +$375K | 0.02% | 243 |
|
|
2013
Q4 | – | Sell |
-655
| Closed | -$37K | – | 314 |
|
|
2013
Q3 | $37K | Hold |
655
| – | – | ﹤0.01% | 331 |
|
|
2013
Q2 | $37K | Buy |
+655
| New | +$37.9K | ﹤0.01% | 320 |
|
Other funds holding CVS
Boston Common Asset Management's CVS Position: Q1 2023 in Review
Boston Common Asset Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 6,594 shares — an estimated $614K sold.
Boston Common Asset Management first reported a position in CVS in Q2 2013 and held it in 30 quarters. The position peaked at $6.72M in Q2 2016. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.
- Boston Common Asset Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
- Boston Common Asset Management sold 6,594 CVS Health shares in Q1 2023, an estimated $614K.
- Boston Common Asset Management first reported a position in CVS Health in Q2 2013 and held it in 30 quarters.
- Boston Common Asset Management's CVS Health position peaked at $6.72M in Q2 2016.
- 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.
Based on Boston Common Asset Management's 13F filing for Q1 2023, filed 17 May 2023.